105 related articles for article (PubMed ID: 15688787)
1. [Lamivudine and alpha-IFN treatment of a severe case of acute hepatitis B].
Manciuc C; Vâţă A; Dorobăţ C; Scurtu R; Petrovici C; Luca V
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):207-9. PubMed ID: 15688787
[TBL] [Abstract][Full Text] [Related]
2. Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.
Seehofer D; Rayes N; Berg T; Neuhaus R; Hopf U; Müller AR; Bechstein WO; Neuhaus P
Transplantation; 2000 Apr; 69(8):1739-42. PubMed ID: 10836394
[TBL] [Abstract][Full Text] [Related]
3. Pediatric issues in new therapies for hepatitis B and C.
Schwarz KB
Curr Gastroenterol Rep; 2003 Jun; 5(3):233-9. PubMed ID: 12734046
[TBL] [Abstract][Full Text] [Related]
4. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
7. Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.
Ozgenc F; Dikici B; Targan S; Doganci T; Akman S; Aydogdu S; Yagci RV
Antivir Ther; 2004 Feb; 9(1):23-6. PubMed ID: 15040533
[TBL] [Abstract][Full Text] [Related]
8. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
9. [Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine].
Pogorzelska J; Flisiak R
Przegl Epidemiol; 2007; 61(3):433-7. PubMed ID: 18069378
[TBL] [Abstract][Full Text] [Related]
10. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
[TBL] [Abstract][Full Text] [Related]
11. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
Terrault NA
Hepatology; 2000 Sep; 32(3):675-7. PubMed ID: 10991635
[No Abstract] [Full Text] [Related]
12. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
D'Antiga L; Aw M; Atkins M; Moorat A; Vergani D; Mieli-Vergani G
J Pediatr; 2006 Feb; 148(2):228-233. PubMed ID: 16492434
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.
Chan HL; Hui AY; Wong VW; Chim AM; Wong ML; Sung JJ
Hepatology; 2005 Jun; 41(6):1357-64. PubMed ID: 15880608
[TBL] [Abstract][Full Text] [Related]
14. The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.
Leemans WF; Flink HJ; Janssen HL; Niesters HG; Schalm SW; de Man RA
J Hepatol; 2006 Mar; 44(3):507-11. PubMed ID: 16457904
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary results of interferon alpha-2a and lamivudine combination therapy regimen in children with chronic hepatitis B].
Aşik Akman S; Cokçeken Okçu S; Anil OH; Köse S; Bakiler AR
Mikrobiyol Bul; 2006; 40(1-2):47-53. PubMed ID: 16775956
[TBL] [Abstract][Full Text] [Related]
16. Current antiviral therapy for chronic hepatitis B.
Lim YS; Suh DJ
J Korean Med Sci; 2004 Aug; 19(4):489-94. PubMed ID: 15308835
[TBL] [Abstract][Full Text] [Related]
17. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Cooksley G
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
[No Abstract] [Full Text] [Related]
18. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine treatment for children with interferon refractory chronic hepatitis B.
Koçak N; Saltik IN; Ozen H; Yüce ; Gürakan F
Hepatology; 2000 Feb; 31(2):545. PubMed ID: 10691379
[No Abstract] [Full Text] [Related]
20. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]